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The work in this thesis was stimulated by the 1961 paper of 
Mihailovic and Jankovic (118) which stated that when the anatomically 
distinct structures of caudate nucleus and hippocampus were injected 
into rabbits, immunologically distinct antibodies resulted. The 
specificities of these antibodies were only demonstrated by their 
ability to specifically inhibit EEG activity of caudate or hippocampus 
when injected intracistemally into cats. The purpose of this thesis 
was to investigate in vitro with the Ouchterlony technique, the claimed 
in vivo EEG specificity of antibodies to caudate nucleus and hippocampus. 
This paper will be divided into an historical and experimental 
section. In the first three historical chapters, the association of 
immunology and neurology is developed from the approach of allergic 
encephalomyelitis and allergic neuritis, (Chapter I), through various 
kinds of brain antigens, (Chapter II), and through the application of 
antibrain antibody to nervous systems, (Chapter III). In the experimental 
section, (Chapters IV and V), the production of antisera to brain antigens 
is described and the results of Ouchterlony testing recorded. In the 
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Chapter I. The Injection of Heterologous and Homologous Nervous 
Tissue into Animals 
The Problem of Paralytic Accidents 
The impetus to investigate the immunological functions of nervous 
tissue can be said to have begun in 1885 with Pasteur's publication 
of a method for the prevention of rabies by the injection of a 
vaccine prepared from dried rabbit spinal cord in which "fixed" rabies 
virus had been grown (1). Variations of Pasteur's original method 
amounted to using combinations of killed vaccines, live vaccines and 
heated vaccines in varying dosage schedules. Common to all the 
therapies the patient received many injections of heterologous nervous 
tissue and usually appreciated effective rabies prophylaxis. 
Some patients however apparently failed to receive rabies 
protection and went on to develop a paralysis which was often fatal. 
There are three documented cases of persons who were bitten by non- 
rabid dogs and then developed paralysis during the course of the 
injections (2, 3, 4). In each case it was possible to isolate rabies 
virus from the brain after death. Death in these cases was most 
probably the result of inadequate attenuation of the fixed virus. 
However, in the majority of these so-called paralytic accidents 
occurring during the course of rabies prophylaxis, the brains were 
free of rabies virus and the symptoms of ascending paralysis with 
urinary and fecal incontinence differed considerably from hydrophobia, 
respiratory distress, dysphagia, and salivation so typical of classical 












in these cases uniformly revealed inflammation, degeneration, 
demyelination, the absence of Negri bodies, and an equal distribution 
of lesions in white and grey matter, with a predominance of cured 
lesions in the dorsal columns. This was not the pathology of rabies. 
In 1940 the Bulletin of the Health Organization of the League 
of Nations reported on the administration of rabies vaccine to 1,060,832 
people in the various Pasteur Institutes of the world from 1890 to 1937 
(5). The number of paralytic accidents in that series was 181, a 
ratio of 1:5861 with one third of the cases fatal and the others 
recovering. Although the rate approximates the current anesthesia 
mortality, administration of rabies vaccine was usually an elective 
procedure, especially when it was not possible to examine the brain 
of the biting animal. Under these conditions, even a risk of 1:6000 
became a significant contraindication and the phenomenon of an 
occasional person developing paralysis after an injection of foreign 
nervous tissue an important practical and academic question. 
Many theories were generated to explain paralytic accidents. 
Pasteur and others (6, 7, 8, 9, 10, 11, and 12) were convinced that 
the attenuated fixed virus of the vaccine "cured" the street virus 
infection and modified its symptoms to a new form, dumb rabies. 
Papamarku (13) thought the fixed virus itself was responsible for 
the paralysis, (the "rage de labatorie"). The concept of a paralytic 
toxin produced by the rabies virus had much appeal (16) because of 
the pathological similarity exhibited in the brains of fatal paralytic 
accidents and in the lesions of encephalitis which occasionally 
! 
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complicated smallpox (16^ measles (17) and smallpox vaccination (18). 
A humoral antibody theory of "defensive ferments" directed against 
nervous tissue was considered by Stuart (19) but not pursued. The 
theory which many proposed was that paralytic accidents were unrelated 
to the presence of fixed virus. Rather the injection of normal nervous 
tissue could in some inknown manner induce a paralysis. 
In 1898 Centanni (20) observed that rabbits tolerated injections 
of brain substance poorly, developing weakness, emaciation and abscesses. 
Aujeszky (21) attempted to immunize dogs against rabies with injections 
of ox brain emulsions using 10 cc of 1:10 ox-cord daily for 18 days. 
The dogs became thin and weak; one of eight animals developed an abscess, 
and another developed convulsions. He also injected rabbits with 
homologous brain emulsion and observed these animals lost weight 
rapidly during the first week. His conclusion was that rabbits were 
more sensitive than dogs to the injection of foreign nervous tissue. 
Delezenne (22) and Armand-Delille (23) while attempting to 
prepare a neurotoxic serum noted that rabbits often died when injected 
with emulsions of dog brain. 
In 1904 Heller and Bertarelli (24) injected various nervous 
preparations (filtrates, alcohol and ether extracts) in many routes 
(intravenous, intraperitoneally, intracerebrally) into mice, rabbits, 
guinea pigs and dogs. They described the development of fever, weakness, 
emaciation, paralysis and occasionally death in their animals. 
According to Hurst (25), Mllller's paper in 1908 (26) was the 
first paper to consider the forgoing evidence and suggest that 
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In 1920 Remlinger (27) injected a rabbit with a total of 14 grans 
of nervous tissue varying from a 2-20% suspension in six graded doses. 
On the 55th experimental day the animal developed a lower paralysis 
and died three days later. At autopsy Remlinger reported "congestion" 
of the lumbar cord. With Bailly (28) he attempted unsuccessfully to 
produce paralytic accidents in dogs by prolonged anti-rabic treatment, 
(101 days). They concluded that it was individual susceptibility 
rather than length of treatment which caused paralysis. 
In an extensive study in 1925 Koritschuner and Schweinburg (30) 
reported upon 8 fatal cases of paralytic accidents in their Vienna 
clinic. They carried out an extensive experiment to duplicate in 
rabbits, the various methods then current for treating human rabies. 
Rabbits were treated with human brain for 14 days prepared according 
to the methods of Pasteur, Babes-Puscariu and Hoegyes.* All animals 
injected with brain tissue lost weight and 16 of 78 animals treated 
with emulsions prepared by the first two methods became paralyzed. 
Animals injected with material prepared according to Hoegyes did not 
become paralyzed. Histological examination of the paralyzed animals 
showed hyperemia, neuronal degeneration, perivascular infiltration, 
and hemorrhage in the spinal cord. Animals dying of other causes 
*Pasteur's original method consisted of air-drying spinal cords for 
varying lengths of time to attenuate the virus. In the first 10 days 
of treatment, cords which had been dried 14 days were used. At the end 
of treatment 5 day cords were used. The Babes-Puscariu modification was 
to use heat attenuated virus in large immunizing doses. Hoegyes achieved 
viral attenuation by dilution of the live virus and injected very small 
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and controls did not present such lesions. They concluded that 
injections of foreign nervous tissue caused paralytic accidents in 
man. Their paper presented the highest experimental mortality then 
published. Many criticized their interpretation and invoked a 
neurotropic virus (31) or additional factors, (32). However, that 
same year (1926) Miyagawa and Ishii (33) reported the development 
of paralysis, paresis, circular movements and ataxia in 37 of 47 
white rats which were injected with 10 per cent suspensions of rabbit 
and ox brains. Their experiments were controlled with liver injections 
which produced no paralysis. Histologically they observed hemorrhage, 
and neuronal and nuclear degeneration. 
Cornwall and Beer (32) conducted experiments to determine the 
minimally effective dose of nervous tissue required to produce paralysis. 
They reported human cases of paralysis with a total dose of 18 mg/kg 
dried cord. In their experiments they were able to paralyze rabbits 
with 94 mg/kg and 500 mg/kg but a rabbit which received 800 mg/kg of 
nervous tissue remained well. Two years later in 1928 Stuart and 
Krikorian (19) produced paralysis in three rabbits wdth doses of 
128, 528, and 900 mg/kg respectively. On histological examination 
the spinal cords of these animals showed an acute myelitis. They 
also produced anaphylaxis with jackal-brain-sensitized rabbits and 
were able to show that the clinical and pathological picture of 
anaphylaxis induced by brain injections \\ras very different from 
paralytic accidents. They concluded that anaphylaxis was not the 
mechanism of paralysis and that an individual predisposition rather 
than the amount of nervous tissue injected was at the root of these accidents. 
. 
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Beginning in 1933 workers at the Hospital of the Rockefeller 
Institute published an important series of papers which finally 
explained the problem of paralysis during rabies treatment. Rivers, 
Sprunt, and Berry (34) first designed experiments to discover the 
relation of vaccine virus to postvaccinal encephalomyelitis. No 
evidence was found to support the idea that vaccine virus placed in 
the cisterna magna of monkeys was capable of producing an acute 
disseminated encephalomyelitis with perivascular demyelination. 
However repeated intramuscular injections of brain extracts and 
brain emulsions into monkeys resulted in 2 of 8 monkeys developing 
an inflammatory reaction with central nervous demyelination. The 
authors, however, wer not willing to accept the 25 per cent disease 
rate as proof of the provocative role of the brain tissue in the 
origin of paralysis. 
Two years later Rivers and Schwentker (35) injected 8 monkeys 
intramuscularly, alternating between aqueous emulsions and alcohol- 
ether extracts of normal rabbit brain. The animals were injected 
three times a week and received from 46 (minimum) to 85 (maximum) 
injections. Six of eight monkeys developed signs of central nervous 
involvement. Ptosis of the eyelids, a mask-like expression of the 
face, facial paralysis, abnormal position of the head, blindness 
and ataxia were common clinical manifestations. Seven of the eight 
monkeys had histological evidence of inflammation, generalized and 
perivascular, and demyelination. Cultures from all brains were sterile 
and all intracerebral innoculations of emulsions from the involved 
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paralytic accidents were in some manner, directly or indirectly, the 
result of injecting foreign nervous tissue into an animal. The role 
of virus was not settled. 
Such experiments were soon repeated and verified by Ferraro and 
Jervis (36) who injected seven monkeys with a minimum of 29 and 
maximum of 103 injections using the same material as Rivers and 
Schwentker. Six of seven animals showed clinical disease and all 
seven presented the appropriate pathological findings. 
Experimental Allergic Encephalomyelitis 
The next significant development in this history of the 
paralysis resulting from the injection of foreign nervous tissue 
hereforth to be called experimental allergic enceohalomyelitis 
followed upon a discovery by Jules Freund that an animal's antibody 
response to an antigen could be greatly hastened and augmented if the 
eliciting antigen was combined in an emulsion with paraffin oil, 
Aquaphor and heat killed tubercle bacilli (37, 38, 39). Moreover, 
a single injection of antigen in this emulsion (or adjuvant) would 
elicit high titer antibody for up to one year, whereas in the past 
multiple injections had been required for the production of high 
titer antibody and continuing injections required to sustain the titer. 
It had already been established that animals dying of allergic 
encephalomyelitis had antibrain antibodies in their sera when Rabat 
(40, 41) advanced the hypothesis in 1946 that the characteristic 
paralysis and microscopic pathology of this disease were caused by 
antibody which formed in response to the injected brain emulsion, and 
. 
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then reacted with the host animal's own central nervous tissue. With 
this hypothesis, Kabat turned to Freund's new adjuvant as the material 
very likely to produce the hypothesized antibrain antibody rapidly, 
and thus reduce the lengthy innoculation time. 
He injected one group of four monkeys with rabbit brain tissue 
in adjuvant, and another group with rabbit lung in adjuvant. Three 
of four monkeys in the first group became ill with the classic signs 
and histology of an acute encephalomyelitis with generalized and 
perivascular demyelination 25 to 33 days after the first injection. 
The lung injected animals remained healthy. In another experiment 
(42) he was able to produce paralysis in monkeys with the spinal 
cord of a three day old rabbit, however, brain from the third day of 
life would not do the same until the rabbit was 12 days old. Fish 
and frog brain, as well as monkey peripheral nerve was found to be 
inactive. For those materials which were found to be encephalitogenic, 
neither formalin fixation, boiling nor treatment with ultrasound altered 
its activity. Kabat attempted, unsuccessfully, to transfer the disease 
to healthy monkeys injecting intravenously up to 200 ml of serum 
withdrawn from paralyzed animals. He also injected serum intracistemally 
and injected serum of rabbits immunized with monkey brain tissue. 
Although all attempts failed Kabat did not give up the antibody 
hypothesis. He concluded his paper with the possibility that the 
central nervous system of the donor animal had absorbed the antibody, 
and suggested that 200 ml was probably not enough serum for transfer. 
At the same time Kabat was injecting his animals, Morgan (43) 












the antigenicity of poliomyelitis virus which she was growing in 
monkey spinal cord. She innoculated monkeys with polio infected 
homologous spinal cord and in 3-5 weeks the majority of animals 
developed the classical paralysis. Animals injected with brain or 
spinal cord showed an equally high rat of disease. Monkeys injected 
with homologous grey matter (estimated to be 10 per cent contaminated 
with white matter) showed only an occasional paralysis. Monkey 
peripheral nerve or kidney was found to be non-paralytic. 
Production of EAE in Animals other than Monkeys 
Once experimental allergic encephalomyelitis (EAE) had been 
established in monkeys, investigators turned toward other animals 
to extend this experimental phenomena. 
In 1947 Freund, Stein and Pisani (44) were able to report the 
production of EAE in guinea pigs with one injection of homologous 
brain in adjuvant. This was immediately confirmed by Kopeloff and 
[), 
Kopeloff (45), Jervis and Koprowsky (46), Alvord (47), and Cazzulo 
and Ferraro (48). Morrison (49) reported EAE in rabbits in 1947 with 
homologous tissue. 
Production of EAE in mice was more difficult but was finally 
achieved after several injections of nervous tissue in adjuvant by 
Olitsky and Yager (50). Moreover, Olitsky, Casal and Tal (51) found 
that susceptibility to EAE varied in different stocks of mice. 
Lumsden unsuccessfully attempted to produce EAE in Albino rats 
with homologous brain in Freund's adjuvant injected by the subcutaneous 


















nervous tissue from rat and guinea pig injected with adjuvant by the 
intracutaneous route. The authors observed that an emulsion containing 
rat spinal cord and adjuvants induced symptoms and lesions in 90-100 
per cent of the rats when injected into the skin, whereas the same 
material failed to produce symptoms or lesions when injected into the 
subcutaneous tissue. In guinea pigs it did not matter which route 
was employed; both produced 100 per cent paralysis. 
In the realm of larger animals Innes (54) injected eight goats, 
eight sheep and nine lambs with an emulsion of normal sheep brain in 
Freund's adjuvant. None of the goats became ill but four of eight 
sheep and six of nine lambs developed paralysis leading to death after 
an unusually long delay for animals treated with Freund's adjuvant. 
For the sheep 53, 74, 132, and 151 days elapsed between the injections 
and death; the period for the lambs was similarly prolonged, 40-118 days. 
Transfer of EAE 
A continuous problem in the studies of EAE has always been one of 
definition. Is EAE an immunological disease? has never been completely 
answered. Lipton (55) summing up the arguments in 1953 stated, "The 
experimental disease has many aspects in common with accepted types 
of allergy. It is characterized by specificity; the encephalitogenic 
material is organ specific, albeit not species-specific, and the 
manifestations of the disease are limited to the CNS. The provoking 
material used is antigenic, inducing the formation of complement-fixing 
antibodies whose specificity is similar to that of the encephalitogenic 
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scant amounts of myelin) is ineffective in evoking the disease or 
formation of complement-fixing antibodies . . . the significance of 
the antibody associated with the disease is not clear. Furthermore, 
there is a discrepancy between the presence of circulating antibodies 
and encephalitis. Only a portion of animals responding with formation 
of these antibodies develop the disease.” Having considered the 
previous attempts to transfer EAE with serum antibody, Lipton and 
Freund (55) decided a more vigorous approach was needed. In their 
first experiment 23 pregnant guinea pigs were given an encephalitogenic 
injection of homologous nervous tissue in adjuvant with the hope that 
the disease if produced by circulating antibody, would pass across 
the placenta and involve the offspring. No lesions were seen in the 
CNS of the infant guinea pigs. 
Considering the evidence that sensitization of the skin to tuber¬ 
culin or simple chemicals could be transferred by living white cells 
but not by serum (56) , Lipton and Freund immunized a group of rats 
with intracutaneous CNS tissue in adjuvant. At varying intervals 
after immunization, these "donor” rats were joined together parabioticallv 
with matched "recipient” littermates. Of 18 donor animals with moderate 
to sever lesions in the CNS, five recipient parabionts had moderate 
to severe lesions in the spinal cord. From this experiment the authors 
had demonstrated that a union which allows free transfer of cells 
and serum, (i.e. parabiosis) would allow for transfer of EAE. Whether 
cells, serum, or both were required to transfer EAE was not answered 
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The transfer problem was finally solved by Paterson (57) in 1959 
working with rats. Lymph node cells were obtained from donor rats 
sensitized to spinal cord and injected into recipient rats which 
had been treated with normal rat spleen cells in the neonatal period, 
thereby rendered immunologically tolerant. He found that the CNS 
lesions in positive recipients were indistinguishable from acute 
I 
EAE lesions found in rats injected with spinal cord adjuvant. 
This work was soon confirmed by Stone (58) using lymph node 
cells in histocompatible guinea pigs. He found that for optimum 
induction of passive disease cells must be transferred before the 
day on which the disease becomes manifest. Lymphoid cells from a 
donor guinea pig of strain 13 would not produce disease in Hartley 
guinea pigs, who have been shown to have the highest susceptibility 
to actively induced allergic encephalomyelitis. 
Experimental Allergic Neuritis 
An experimental allergic disease of this peripheral nervous system 
was produced by Waksman and Adams (59) following the injection of 
rabbit sciatic nerve or spinal ganglia into rabbits with adjuvant. 
This new disease, experimental allergic neuritis, (EAN) differed 
clinically and histologically from EAE. It presented itself as a 
symmetrical, ataxic paresis of the extremities without fecal or urinary 
incontinence and was rarely fatal. Histologically the spinal cord, 
brain and meninges were always normal. The spinal ganglia, dorsal 
roots and peripheral nerves shared the pathology which included 
inflammation with lymphocytes and histiocytes, neurophagia and demyelination. 
As in EAE, which many believe to be the experimental model for multiple 
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for "acute infectious polyneuritis" or the Guillain-Barre-Landry 
syndrome. 
Waksman and Adams were able to demonstrate this disease in 
guinea pigs, rabbits and mice (60) and Astrum and Waksman (61) were 
able to transfer it with lymph node cells. To the present time 
neither EAE or EAN has been transferred by serum. 
Recent Progress in EAE 
The lesions of EAE have been shown to preferentially appear in 
areas of cyanide encephalopathy (62) or where an electrolytic lesion 
has been produced (63). In both examples local alterations in the 
blood-brain barrier have been evoked as the probable explanations. 
Scheinberg and Lee (64) reported on the production of EAE in 
mice induced with a mouse glioma adjuvant mixture. The tumor which 
was a methylcholanthrene induced ependymoblastoma did not demonstrate 
myelin by the usual stains. H. pertussis vaccine was injected 
intraperitoneally prior to immunization. This work has not yet been 
replicated. 
Studies have been made on the differential susceptibility of 
various rat strains to develop EAE without the aid of adjuvant. With 
a pretreatment injection of H. pertussis vaccine four days before the 
injection of brain tissue, Lewis CD F, Fischer 334, Buffalo, M 520/N 
and Wistar/Furth rats showed a clinical incidence of EAE of 86, 68, 25, 
75, 17, and 0 per cent respectively. The histological severity 
paralleled the clinical observations (65). It was also possible to 
produce EAE in CD F rats without adjuvant or pertussis pretreatment 




















histopathology, (66). The same authors were also able to produce 
HAN in CD F rats using Freunds adjuvant without tubercle bacilli (67). 
Most recently, Levine and Wenk have described a hyperacute form 
of allergic encephalomyelitis in Lewis rats (68). This experimental 
disease has a reproducible onset of 6 days in adrenalectomized rats 
and 7-8 days in unoperated animals. The hyperacute form is induced 
only when aqueous spinal cord and aqueous pertussis vaccine are 
injected together. When Freund's adjuvant was used, the onset of 
disease was 9-10 days. Moreover, the histopathology of the hyperacute 
form of HAH is characterized by large numbers of neutrophils, (not 
usually seen in ordinary EAE) as well as mononuclear leukocytes, 
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Chapter II. The Specificity of the Nervous System 
Having now dealt with the essentially clinical and pathological 
effects of injections of gross nervous tissue, let us examine some 
of the work which has been done in the area of separating and 
analyzing central nervous tissue with respect to its antigenicity, 
the search for the EAE antigen being a very small part of this area 
of investigation. 
A convenient manner of subdividing the antigens of the CNS which 
also has an historical basis, is to consider the alcohol soluble, 
alcohol insoluble, water soluble and EAE antigens separately. 
Alcohol Soluble Antigens of the CNS 
The use of alcoholic extracts of brain in the early German 
investigations of nervous tissue specificity has its roots in the 
history of German immunology. Soon after Landsteiner had produced 
a hemolytic serum it was shown that an alcoholic extract of 
erythrocytes would block his hemolytic reaction (69). It was also 
demonstrated that hemolysins could be produced by the injection of 
alcoholic extracts of red cells alone (70). 
The work of Wasserman (71) on the serodiagnosis of syphillis 
also contributed to the use of alcoholic extracts. After observing 
that the serum from a syphilitic patient would fix complement with 
an alcoholic extract of syphilitic tissue, Wasserman discovered that 
the "lipoid" or alcohol soluble antigen of even normal tissue would 
react with syphilitic sera 
. 
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In 1911 Forssman (72) discovered an alcohol soluble hapten 
initially in guinea pig tissue, (and later in alcoholic extracts 
throughout the plant and animal kingdom) which would lyse sheep 
erythrocytes. These alcohol soluble F (Forssman) antigens were 
also found to be resistent to boiling. 
The application of "lipoid'1 antigens to brain immunology was 
first described by Brandt, Guth, and Mllller in 1926 (73). They immunized 
rabbits with 18 daily injections of beef brain lipoid mixed with pig 
serum. The resulting antiserum fixed complement with alcoholic 
extracts of beef, human, pig and guinea pig brain and was negative 
or weakly positive with similar extracts of other organs. 
Further experiments by Witebsky and Steinfield (74) Hermann and 
Steinfield (75) and Plaut and Kassowitz (76) firmly established the 
organ specificity of anti brain-lipoid antibodies prepared with the 
injection of alcohol extracts. An antibody to brain lipoid was found 
to react well with all brain lipoids. 
When Witebsky immunized rabbits with saline suspensions of brain 
he obtained two classes of antibodies. Some sera reacted with all 
species of boiled or native mammalian brain. Other sera only reacted 
with unheated homologous brain suspensions. Those sera which were 
organ specific contained antibodies against lipoid antigens. The 
sera whose reaction was limited to homologous antigen did not contain 
antibodies to lipoid antigen (74). 
Using antibodies to lipoid antigens, Witebsky and Behrens (77) 
demonstrated an immunologic difference between the anterior and 
..... . . . . •. * • • 
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posterior pituitary and with Klinke, Witebsky was able to differentiate 
between the cortex and medulla of the adrenal gland (78). 
In 1934 Reichner and Witebsky (79) immunized rabbits with boiled 
suspensions of selected brain regions. White matter was obtained 
from the centrum semiovale and sciatic nerve while grey matter was 
removed from the hippocampus and the caudate nucleus. Antisera 
produced to these boiled suspensions were found to react organ- 
specifically with an alcoholic extract of whole brain. In the 
complement fixation reaction antibodies to the grey areas could be 
distinguished from those prepared against white matter by reactions 
with "grey" and "white" antigens respectively. Anti caudate nucleus 
and anti hippocampus antisera fixed complement avidly with both grey 
matter alcoholic extracts; each antisera reacted weakly with both 
white matter extracts. In similar manner, the anti white matter 
antibodies reacted strongly with both of the white matter alcoholic 
extracts and weakly with the grey matter extracts. Antibodies 
prepared against boiled suspensions of medualla oblongata, cerebellum 
and sacral spinal cord were found to behave as white matter antibodies. 
When an embryonic mammalian brain and a fish brain were tested against 
the two species of antibodies (anti white and anti grey) it was found 
that the anti white matter antibodies reacted with fish brain but 
not with the embryonic mammalian brain and conversely, the anti grey 
matter antibodies reacted with the mammalian embryonic brain and not 
the fish brain. Today, 32 years later, this experiment remains one 
of the most significant demonstrations of regional brain specificity. 
, 
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Lewis (80) immunized rabbits with twice a week intravenous 
injections of brain suspensions (saline) and brain alcoholic extracts. 
Beef, rat, rabbit, and guinea pig brains were used. The saline 
suspensions were mixed with normal rabbit serum before injection 
whereas the lipoid extracts were combined with or MactivatedM with 
pig serum. All preparations were found to be antigenic in the rabbit 
except for rabbit brain suspension in normal rabbit serum. The 
resulting antibodies were indistinguishable when tested against 
homologous and heterologous antigens from both methods of preparation, 
using the complement fixation technique. All anti brain antisera 
were brain specific (organ specific) when tested with homologous 
and heterologous organs (heart, liver, spleen, kidney, liver) except 
that each sera displayed a weaker cross-reaction with testicle antigens 
of all species. Lewis extended Witebsky’s observation of organ 
specificity by the demonstration of an equally strong reaction of 
antibrain sera against the saline suspensions and the alcoholic 
extracts of brains from 8 mammals, 4 birds, 2 fish and a frog. 
When antibrain sera was tested against brain parts (cortex, thalamus, 
basal ganglion, corpora quadrigemina, cerebral peduncles, pons, 
cerebellum, medulla and cord) no significant difference was found 
in the ability of any region to fix complement with antibrain sera. 
It was also observed that antibrain sera fixed complement markedly 
in the presence of cholesterol but not with lecithin. 
Neither Witebsky and Steinfield (74) nor Lewis (80) were able to 
produce antibodies in the rabbit to suspensions of homologous brain. 
, • , ■ . 














More generally, most alcoholic extracts of antigenic tissues were 
found to be non-antigenic until mixed with a foreign protein, often 
pig serum. This enhancement phenomena was first described by 
Landsteiner (81) (82) while working with the Forssman hapten. The 
hapten extracted from horse kidney with alcohol was observed to have 
a strong affinity for Forssman antibodies but was unable to elicit 
antibody formation when injected alone. Landsteiner was able to 
endow immunizing capacity to the hapten by mixing it with a foreign 
protein. 
The production of antigenicity with the addition of a foreign 
serum was called the conveyer method, "Kombinationsimmunisierung" or 
the "Schlepper Function." Landsteiner (81) thought that the hapten 
might enter into a loose combination with the conveying protein. 
Sachs (83) and Weil (84) suggested that the foreign protein served 
as an envelope to allow the non-protein matter in enter the cells. 
However, none of the theories were able to explain other observations 
that in some cases the conveyor could be replaced by adsorbants like 
kaolin or A1(0H)^, (85, 86, 87, 88), 
However, without a complete explanation, addition of a foreign 
protein allowed the reproducible production of antisera to alcoholic 
extracts of brain, testicle, blood cells, etc. Moreover, Sachs (83) 
demonstrated that when a rabbit was injected with an ethanolic extract 
of organs (homologous or heterologous) by the above method, the 
resulting serum exactly mimiced the reactivity of a positive syphilitic 
serum in the Wassermann reaction. 
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A special investigation of the antigenicity of homologous brain 
preparations in the rabbit was designed by Schwentker and Rivers (89). 
Five rabbit brain innoculants were prepared: 
1. Emulsions of fresh brain. 
2. Emulsions of fresh brain with pig serum. 
3. Emulsions of autolyzed brain prepared by allowing 
sterile normal rabbit brain to stand at room temperature 
for 5 to 30 days. 
4. Emulsions of brain infected with vaccine virus. 
5. Alcoholic extracts of brain with pig serum. 
Rabbits received 10 intraperitoneal injections of 5 cc of one of the 
above preparations. Their sera was then collected and tested by 
complement fixation against both emulsions and alcoholic extracts of 
rabbit brain. High titer antibodies (1:80) were produced in the rabbits 
injected with emulsions #3 and #4. Low titer antibodies (1:20) were 
produced in animals receiving #2 and #5. No antibodies were produced 
in rabbits injected with #1. 
When tested for specificity, the sera resulting from the injection 
of autolyzed brain fixed complement organ specifically only with 
alcoholic brain extracts. When aqueous emulsions were substituted, 
the sera reacted with all organs. These non-specific antibodies 
were absorbable with an aqueous emulsion of rabbit kidney. The 
absorbed antisera then tested brain specifically with both aqueous 
and ethanolic antigens. In converse fashion it was possible to 
absorb the specific anti brain antibodies and leave behind only the 
non-specific reactivity. Such production of non-specific antibodies 
is in agreement with other experiments in which heterologous antigens 
in aqueous form were used for immunization. It must be expected 
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that water soluble antigens of connective tissue, ground substance, 
blood vessels, etc., would be included in an aqueous emulsion of 
brain tissue and that antibodies to these ''contaminants'’ would fix 
complement when such an aqueous emulsion is- the antigen. 
Further experiments were conducted by Schwentker and Rivers to 
better locate the brain antigen. When aqueous emulsions of known 
amounts of white and grey matter were tested against the antibrain 
sera it was found that white matter was six times more antigenic 
than grey. Moreover, when a series of rabbit brains from fetus to 
maturity were tested, the "brain antigen" was found to parallel 
development and was not present in fetal brains. It was the authors' 
conclusion that the antigen concentration paralleled the development 
of myelin in brain. 
In the tradition of Reichner and Witebsky, Jankovic, Isakovic 
and Mihailovic (93) removed frontal cortex, occipital cortex, temporal 
cortex, cerebellar cortex, caudate nucleus, thalamus, cerebral white 
matter, medulla and spinal cord from cat, dog, ox, monkey and human. 
Each of these brain regions was extracted with ethanol and the lipid 
residues were combined with Freund's adjuvant and injected into 
rabbits. Antisera to all the lipid extracts were found to be highly 
organ specific, but no regional specificity was found. 
The most recent contributions to the nature of the "lipid" 
organ specific antigen of brain comes from the work of Niedieck and 
Pette (94), Rapport, Graf, Autilio and Norton (95), and Joffe and 
Rapport (96). These authors have shown that the organ specific 
. 
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alcohol soluble thermostabile antigen of brain is galactocerebroside. 
When an animal was immunized with galactocerebroside isolated from 
bovine spinal cord all of the activity in the antisera could be 
absorbed with either myelin or galactocerebroside. 
It was also found that the antibody which reacted with galacto¬ 
cerebroside was identical with the antibody which reacted with myelin. 
A significant difference however, was that for the complete absorption 
of galactocerebroside the presence of the auxiliary lipid lecithin 
was required, whereas myelin, a complete lipid, reacted alone. With 
a sensitivity of three complement units, 7 ug of myelin was detectable. 
Antisera prepared against particulate fractions of bovine brain con¬ 
tained the anti galactocerebroside antibodies but in addition, contained 
other antibodies against non-galactocerebroside determinants. 
Alcohol Insoluble Antigens of CNS 
Bailey and Gardner (90, 91) used the anaphylactic response of 
guinea pigs to demonstrate the organ specificity of the brain antigen. 
They immunized rabbits with a sedimented, heat killed vaccine of 
Pasteurella boviseptica grown in an infusion broth prepared from 
rabbit or rat brain. The antiserum resulting was used to produce 
passive sensitivity in guinea pigs 24 hours before testing with 
various autoclaved organ preparations. 
When guinea pigs were sensitized with anti rabbit brain broth 
18 rabbit tissues tested negative except for brain which produced 
a fatal anaphylaxis. A slight reaction was observed with testicle. 
The autoclaved broths of 14 other mammalian brains produced a fatal 













anaphylactic reaction; chicken brain produced only a slight response 
and fish, duck and frog brain were inactive. 
When the guinea pigs were sensitized with anti rat brain broth 
only rat brain, sciatic nerve and a carcinoma derived from rat mammary 
gland produced death. All other rat tissues were inactive. (Note, 
sciatic nerve was not tested in the first experiment.) 
In another experiment the anaphylactogen was demonstrated in rat 
brain beginning at 17 days of age in bovine white matter but not in 
grey matter. Fetal brains from rat, guinea pig or rabbit were inactive. 
It was also possible to show an increasing severity of the anaphylactic 
response as a guinea pig brain matured from 2 days to 6 months. The 
anaphylactogen was found to be alcohol insoluble, thermostabile, and 
water soluble. It was not dialyzable. Bailey and Gardner did not 
consider their antigen to be a lipoid because an autoclaved alcoholic 
extract of brain was negative in their hands. Rather, they felt their 
antigen was a polysaccharide or an altered protein produced by the 
effects of steam and pressure. 
Milgram, Tuggac, Cambell and Witebsky (92) have recently defined 
organ specific antigens of brain and adrenal which are saline soluble, 
alcohol insoluble and stable at 100°C. They referred to them as BE 
preparations for their resistance to boiling and ethanol insolubility. 
This group prepared antisera in rabbits to BE of bovine, porcine and 
human brain. Antisera to human and bovine brain BE reacted with its 
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Anti porcine brain BE had to first be absorbed with porcine kidney 
BE for its similar specificity to be established. 
The BE of brain was not found as universally antigenic as brain 
lipid. The three brain BE preparations were cross tested against 
their corresponding antisera. The anti human brain serum combined 
with the homologous brain preparation only, anti bovine brain serum 
combined with bovine and porcine brain preparations and anti 
porcine brain serum combined with all three BE preparations. These 
reactivities were confirmed with inhibition studies. 
Whatever the BE antigen may be, it is apparently present in 
native brain suspensions. Anti bovine brain BE sera reacted with 
suspensions of bovine brain exclusively and anti bovine brain 
suspension reacted in similar manner with bovine brain BE. When 
the BE of parts of bovine brain were tested with the anti bovine 
brain BE serum, the BE of grey matter had a reaction titer 30 times 
higher than the BE of white matter. Thus, the BE factor must be 
different from Bailey and Gardners' anaphylactogen which was mostly 
in white matter (91) even though both antigens are alcohol insoluble 
and thermostable. 
Milgram's group also showed that the antibody to brain BE is 
very different from the antibody to brain lipid. Anti porcine and 
bovine brain BE did not react with their homologous alcoholic brain 
extracts, whereas antisera to procine and bovine brain suspensions 












Water-Soluble Protein Antigens of the CNS 
Investigations of the water-soluble protein antigens of the 
nervous system were delayed until electrophoresis and immunoelectrophoresis 
became firmly established as practical laboratory techniques. In the 
early 1960's Schalekamp and Kuyken (97) obtained 13 electrophoretic 
fractions of whole brain extract and Van Sande (98) obtained 17 
fractions using high voltage electrophoresis. 
Employing a starch gel medium, Bailey and Heald (99) performed 
electrophoresis on protein extracts from different parts of human 
and guinea pig brain. With this technique, human cerebral cortex 
yielded 10 components while cerebellum yielded only eight. Moreover, 
at pH 8.3, 0.04 M borate buffer, human cortex displayed three negatively 
charged components which were not present in the cerebellum. Proteins 
of the guinea pig brain were markedly different from human brain by 
electrophoresis. The authors searched for changes in protein 
patterns following anesthesia, electroshock and metrazol shock, but 
none were found (100). 
The most complete separation of cerebral proteins to date has 
been achieved by Bogoch, Rajan and Belval (101) with the combined 
methods of column chromatography and disk gel-electrophoresis. These 
workers exhaustively extracted the proteins from human grey matter 
and then collected 50 fractions, classified unique by protein, hexose, 
hexosamine and neuraminic acid analysis, from a diethyl amino ethyl 
(DEAE) cellulose column. Each of these 50 chromatographic fractions 
were then examined by disk acrylamide gel-electrophoresis, resolving 
between two and eleven clearly separated protein zones for each of 
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the 50 fractions. Allowing for overlap the authors claimed to have 
identified over 100 cerebral proteins. Curiously, one of these 
sub-subfractions was found to be greatly elevated in a brain from 
a patient with Tay Sachs disease (102) . 
Moore and McGregor (103) also chromatographed the soluble 
proteins of human brain on DEAE cellulose and followed with starch 
gel electrophoresis of each column fraction. They too obtained from 
70-100 fractions, however, these workers also studied the soluble 
proteins of liver as a control. From 100-200 discretely staining 
bands on starch electrophoresis, these investigators found one constant 
fast moving acidic protein present only in brain and absent in a liver 
of rat, rabbit, beef and monkey. This protein was called S 100 by 
Moore because it was soluble in saturated ammonium sulfate solution. 
Further investigations (104) identified this protein uniquely 
in the brains of: hog, hamster, guinea pig, mouse, dog, human, turkey, 
eagle, alligator, black snake, turtle, pompano and red snapper. It 
was found in several parts of the nervous system of the rabbit: whole 
brain, grey and white matter, cerebrum, cerebellum, brain stem, spinal 
cord, sciatic nerve and vagus nerve. It was also found in beef retina 
and in sciatic nerve and spinal cord of rat. Its concentration has 
been estimated to be 0.6 per cent of the total soluble protein of 
beef brain. S 100 has not yet been located in any non-nervous tissue! 
Using antisera prepared to the S 100 protein, it was estimated 
that brain soluble extracts contain from 1000 to 10,000 times as much 
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weight of the protein to be about 30,000. On the basis of its 
distribution, he has suggested that S 100 is probably neuronal 
protein and not part of the myelin sheath. 
What is the role of S 100 in the nervous system? Rubin and 
Stenzel (105) prepared a brain cell-free actively synthesizing system 
which was allowed to incorporate C*4 leucine. After one hour of 
active synthesis Moore's S 100 protein and its antibody were added 
to the reaction system to allow co-precipitation with any radioactive 
acidic proteins which were being newly synthesized. After four days 
of incubation in the cold 21 per cent of the soluble protein synthesized 
in the cell-free system had bound in immune co-precipitation to the 
S 100-anti S 100 complex. In control co-precipitations 9.2 per cent 
of the protein bound non specifically to RNase-anti RNase and 7.0 
per cent to egg albumin-anti egg albumin. 
Hyden and McEwen (106) have localized S 100 principally in 
glial cells. They extracted equal amounts of soluble proteins from 
50 rabbit Dieters' nerve cells, and the corresponding amount of glia 
and brain stem homogenates. With a micro capillar)'1 gel-diffusion 
method, immune precipitation occurred only when the proteins of 
brain homogenate and glia were tested with the anti-S 100 sera. No 
precipitation occurred with neuronal proteins. With the sandwich 
technique, fluorescent antibody analysis was used to locate S 100 
antigen in the rabbit brain stem. Specific fluorescence was seen 
in the glia, but also in the big Dieter's nerve cells. The neuronal 














Attempts at quantitation revealed that the concentration of S 100 
in neurons was at least less than one fifth that of the proteins 
of the whole Dieter's nucleus. 
The most recent studies of S 100 (107) have shown that this 
assumedly homogenous protein can be separated into five components 
with electrophoresis in 15 per cent acrylamide gel. Only two of 
the five bands react with antibody prepared against the unseparated 
S 100. 
Encephalitogenic Antigens of Brain 
There are so many apparently unrelated subfractions of brain 
with encephalitogenic activity which have been proposed as "the 
antigen" that a discussion of this area is not only confusing but 
contradictory. The history of the problem is best summed up by 
Lumsden (122) in his recent paper which appears to have explained 
the ubiquitous nature of the EAE antigen. 
"Firstly there was the evidence of Kabat, Wolf 
and Bezer (41) relating the appearance of encephalito- 
genicity to myelinogenesis. Laatsch, Kies, Gordon and 
Alvord (122), using an ultracentrifugation technique 
controlled by electron microscopy, have clearly confirmed 
that the active substance is related to lamellar myelin. 
Chemically, the early evidence (123) that at least some 
encephalitogenic substance resisted autoclaving and 
treatment with formalin, alcohol, chloroform and ether, 
and that some was extractable with the sphingomyelin and 
cerebroside fraction, was overshadowed by the later enthusiasm 
for soluble protein, which might have been expected to be 
more labile. At the Bethesda symposium (124) it was widely 
agreed that there were three groups of EAE antigens: (i) 
water-soluble proteins, (ii) fat-soluble proteolipids, and 
(iii) a water-insoluble glycoprotein or 'collagen-like' 
protein. The prevailing conclusion of Waksman (125) was that 
'several substances' were responsible." 
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Lumsden and his group set to testing the biologic activity 
(in the sense of EA-encephalitogenicity with Freund's adjuvant) 
of all extracts and residues throughout all major extraction 
schedules of basic proteins, proteolipids, and collagen-like proteins, 
(the three major candidates for the EAE antigen). Altogether, 173 
fractions and residues were tested, each in groups of ten guinea 
pigs at different dose levels. According to his paper, the common 
denominator of EAE-activity in every fraction which was active was 
a dialysable basic small polypeptide (BSP) with the following 
properties: 
1. "It comprises a specific polypeptide or polypeptide 
species responsible is; some as yet undetermined way for 
the encephalogenicity of all EAE-active compounds in 
CNS tissue. 
2. It is released by spontaneous breakdown of larger 
basic polypeptides and basic protein. 
3. It is itself highly basic, migrating rapidly to the 
cathode on electrophoresis on acrylamide gel in formic- 
acetic acid buffer at pH 2. 
4. In addition to its association with basic protein it may 
also be capable of binding with at least one type of 
anodic protein and with the proteins constituting the 
neurokeratin moiety of proteolipid. 
5. It may exist in bound or complexed forms with lipids, 
phosphatides and gangliosides. 
6. In all its forms so far examined it has given a faint 
antnrone reaction carbohydrate. 
7. Preliminary molecular weight studies give a value of about 
4000. Current studies of more highly purified material 
indicates an even lower molecular weight." 





Chapter III. The Application of Antibody to Functioning Nervous 
Systems 
The application of antibrain antibody to functional studies of the 
nervous system is in this author’s view, the most exciting activity in 
this recently named field of immuno-neurology. The hope of producing 
a specific lesion in the nervous system with antibody, and the further 
hope that very specific antibodies will produce similarly specific 
lesions has concerned some investigators enough to consider antibody 
for a new tool. At present in the field of neurophysiology the non- 
behavioral methods available for studying brain function include 
stimulation and recording via implanted electrodes, chemical 
alterations with local or systemic application of metabolic antagonists 
or hormones, or mechanical interference either by heat coagulation, cryo 
techniques, alcohol necrosis, ultrasound, x ray, or surgery. Except 
for metabolic antagonists, none of these methods contain the quality 
of specificity which is implicit in the concept of antibody function. 
In the next group of experiments some of the published applications 
of antibody to functioning nervous systems will be presented. 
Early Animal Injections 
The earliest whole animal experiments with "neurotoxic" sera 
were conducted by Delezenne in 1900 (22). In this study antibody 
was produced in ducks who had received intraperitoneal injections 
of dog forebrain, cerebellum, brain stem, or spinal cord over a period 
of two months. Those ducks which survived this procedure were bled 















injecting the sera into dogs it was first determined that dogs could 
tolerate the instillation of 0.5-0.6 ml/kg of normal duck serum into 
their frontal lobes without any signs of behavioral abnormalities. 
However, when similar amounts of test serum were injected most of 
the animals becam quickly paralyzed, rarely showed convulsions and 
died in respiratory arrest. Animals given a smaller amount, 0.3-0.4 
ml/kg, "collapsed, showed convulsive movements that were rarely 
generalized, became paralyzed slowly, breathed stertorously and died 
in respiratory arrest several hours later. Animals given 0.1-0.2 ml/kg 
rarely demonstrated any effect in the first few minutes after the 
injection except that most of them tried to run away and if they 
were not held ran into a corner. Very soon they began scratching 
and walking became difficult. About a half hour later paralysis began 
and they had great difficulty standing. Some dogs now showed clear 
epileptic signs: loud crying, salivation, clonic and tonic convulsions 
which were repeated several times before being followed by clonic 
convulsions that intensified with time. Throughout this period the 
dogs continually moved their heads and limbs in an uncordinated manner. 
This excitatory period lasted 7 to 8 hours and was followed by a period 
of spastic paralvsis similar to that shown by the animals receiving 
high doses and ended in death." 
This work was repeated by Centanni who in the same year immunized 
a lamb with 7 months of intraperitoneal injections of rabbit brain. 
The lamb serum killed a rabbit in 48 hours when 0.5 ml was injected 
intracerebrally. Intravenous injections produced no effect (108). 
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In Delezenne's laboratory, Armand-Dellile prepared "neurotoxic" 
serum against dog brain in the guinea pig. His macroscopic obser¬ 
vations of the killed dogs' brains revealed congestion and occasional 
ecchymosis of the pia but curiously never any bleeding at the needle 
sight. Microscopically the most significant lesion was the extreme 
degree of congesting and dilatation of the blood vessels. Chromatolysis 
was present in all of the motor nuclei. None of these effects occurred 
in the control (23). 
These kinds of experiments died out for forty years to reappear 
in the late 1940's when investigators attempted unsuccessfully to 
transfer the clinical and pathological manifestations of EAE with 
serum, (42, 43, 44). The conclusions of the EAE investigators was 
that the sera of EAE animals did not cause any disturbance when 
injected intraperitoneallv, intravenously, or intracistemally. 
Hurst argued however, that the sera of EAE animals did not constantly 
show complement fixing antibrain antibodies, whereas when animals 
were injected with suspensions or alcoholic extracts of brain they 
always produced brain-specific antisera. He suggested that this might 
explain the negative transfer results. 
Hurst himself injected monkeys intra-arterially and intra¬ 
cistemally with goat anti-monkey brain sera and anti-monkey spleen 
sera. His two papers carefully describe the necro-pathology resulting 
from the injections but he failed to demonstrate that intracisternal 
or intra-arterial injections of "neurotoxic" sera differed in 
activity from anti-spleen sera. Moreover, the anti-spleen sera was 
















Antibody In Tissue Cultures 
There were also investigators who put antibody into their 
tissue cultures. Lambert and Hanes, reporting on the effect of 
immune serum on the growth of a mouse sarcoma in 1911, were probably 
the first of this group (109), The first application of antibrain 
serum to cultures of neuronal cells was in Kimura's laboratory in 
1928. In a brief report a specific cytotoxic effect of rabbit anti¬ 
brain sera upon cells of the CNS was described (111). 
Twenty years later Grunwalt decided that tissue culture would 
be a valuable tool for evaluating anti-brain sera (110). He prepared 
antisera in rabbits to three different preparations of newly hatched 
chicken brains: whole brain in saline, the alocohol-soluble fraction, 
and the alcohol insoluble residue. These three antisera were then 
added in 25 per cent concentration to hanging drop cultures of 9 
and 13 day chick embryo spinal cords and their effects upon cell 
growth observed. 
The effects of the anti-whole brain and the anti-alcohol insoluble 
residue were indistinguishable: both inhibited the outgrowth of 
fibers and cells in the 9 and 13 day cultures. However, the anti-brain 
sera obtained from injection of the alcohol soluble fraction of 
brain inhibited growth in the 13 day culture but had no effect upon 
growth in the 9 day culture. The suggestion was made that there must 
be two different antigens in the brain of the chick, one is alcohol 
insoluble and appears early; the other is alcohol soluble and appears 
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More recently, Bomstein and Appel, in their attempt to set 
up a model system to study demyelination, have described a specific 
and characteristic reaction in myelinated cultures of newborn 
rat cerebellum which occurs whenever the serum from animals with 
experimental allergic encephalomyelitis or from humans with active 
multiple sclerosis is introduced (112, 113, 114). 
'•The reaction may begin within an hour after 
exposure to high concentrations of EAE serum. The 
first observable alteration appears as a swelling of 
neuroglia, visualized directly with time-lapse 
cinematography, or as a displacement or deviation of 
myelinated axons in the more usual photomicrography. 
At about the same time, the myelin sheaths appear 
brighter and more distinct. Neuroglia continue to 
swell throughout the acute course of the reaction. 
"The myelin sheaths soon become disfigured by 
fusiform swellings at irregular intervals along the length 
of the axons. Many swellings enlarge further to protrude 
grotesquely into surrounding areas. They may break 
away to become myelin fragments. The fragmentation, 
however, does not seem to be the only manifestation of 
myelin damage, for whether or not this myelinolysis has 
occurred, the myelin seems simply to melt away. Thus, 
apparently intact sheaths as well as isolated myelin 
fragments more or less rapidly lose their characteristic 
refringence, become less and less distinct, and finally 
fade into a background of neuroglia, neurons, and small 
fat granules. 
"Meanwhile, some neuroglia have become enormously 
swollen. Their pycnotic nuclei frequently lie against 
the cell membrane with retracted elements of the cytoplasm, 
while the main body of the cell i£ filled with fluid and 
particles in Brownian movement. 
"At this time, neurons seem little affected. Some 
nuclei tend to assume eccentric positions; such neurons 
stain less intensely with cresyl violet than do the normal 
controls. The axis cylinders appear intact when viewed in 
the living state with bright field or phase contrast 
illumination or when fixed and stained with Bodian's 
silver impregnation technique. 
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"Phagocytic activity is remarkably slight at this 
time and ependymal cells seem totally unaffected. 
"The tissue is far from overwhelmed by the reaction. 
Removal of the foreign serum and its replacement by 
normal nutrient medium halts the process. Further 
studies, moreover, demonstrated that remyelination may 
occur after a short recovery period. 
"Myelinated cultures of fetal rat spinal ganglia 
failed to react in any way during a 48 hour exposure to a 
20 per cent concentration of EAE acute or its paired 
normal serum. A1 aliquot of the former, simultaneously 
applied to cultures of rat cerebellum, produced a total 
demyelination of the central nervous tissue in less than 
12 hours." 
The demyelinating activity has been found to be complement dependent 
and resides within the gamma-2 globulin fraction, one microgram of 
which is sufficient to cause demyelination in a culture in 24 hours. 
Exposure to homologous or heterologous brain removes the activity 
whereas non-nervous tissue does not. Fluorescent antibody studies 
have located the EAE globulin on the myelin sheath and glial 
membrane during the process of demyelination. 
Bornstein and Crain (115) have also applied antibody to myelinated 
cultures of cerebral neocortex and spinal cord in which the response 
to electrical stimulation was measured. Exposure to antibody not 
only produced the characteristic demyelination, but produced 
extensive alteration in the bioelectric properties of the tissue 
long before any morphological changes had been detected. The first 
responses to disappear were those electrical patterns characteristic 
of snyaptic transmission, often within a few minutes of application, 
leaving the axon spikes. With time, the threshold for direct 


















. : * • • ' r.'ii : • ■ r;i■ r■» 
36 
function returned. Human serum from patients with acute multiple 
sclerosis also blocked intraneuronal transmission but a 50 per 
cent concentration was required to equal the effect of 10 per 
cent rabbit EAE serum. 
The last group of experiments to be described represent what 
may be a major breakthrough in the application of antibodies to 
the nervous system. These experiments propose, that in addition 
to the specificities of white matter, grey matter, peripheral 
nerves and central nerves, and general brain, there may be an 
intraregional specificity among grey matter structures. 
Functional Regional Specificity 
The first experiment of this kind was performed by Mihailovic 
and Jankovic in 1961 (118). For this study whole cat caudate nucleus 
was carefully dissected, homogenized, mixed with Freund's adjuvant 
and injected subcutaneously into rabbits (1.0 g. wet tissue/kg body 
weight). The rabbit serum was ammonium sulfate fractionated and 
the immune globulin tested by complement fixation and gel-diffusion 
against the saline extract of cat caudate. The reaction between 
the rabbit gamma globulin and the caudate yielded 2-3 lines in gel 
and a titer of 1:128-1:256 in complement fixation. The antisera 
was apparently not tested with any other brain antigens. 
The antibody was then tested in cats who were prepared with 
a cannula inserted into the lateral ventricle on one side, and 
electrodes implanted in frontal cortex, frontal white matter, 
caudate nucleus, hippocampus, hypothalamus, thalamus, and brain 
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stem reticular formation in the opposite side. Cats were injected 
intraventricularly with 0.3 ml of either immune gamma globulin, 
normal gamma globulin, or normal saline two or three times a day 
for a period of four days. Both control groups demonstrated no 
significant changes in their electroencephalogram during a month 
of observation. For those animals injected with the immune 
globulin the following changes were noted: 
"The first stage was characterized by the 
appearance of spikes and high-voltage sharp waves 
localized in the caudate. These transient irritative 
abnormalities became apparent on the third day of 
antibody administration, and disappeared two or 
three days afterwards. The second, also transient 
stage was characterized by slight general accentuation 
of background activity and by sporadic appearance of 
diffuse abnormalities consisting of bursts of 4-6/sec 
high voltage waves, in all leads. Such activity 
outlasted the disappearance of spikes and sharp waves 
in the caudate for several days. The third stage was 
characterized by gradual slowing down, progressive 
decrease in the amplitude and almost complete dis¬ 
appearance of spontaneous electrical activity of the 
caudate nucleus within a month after antibody 
administration." 
No change in the activity of the caudate nucleus could be observed in 
the animals treated similarly with anti-hippocampus antibody. Incidental 
observations showed that evoked potentials to auditory stimuli were 
modified as was the activity propogated to the caudate during 
seizures induced by electrical stimulation of the hippocampus. 
In another in vivo experiment by the same group (119) cats were 
injected intraventricularly with anti-caudate, anti-hippocampus, 
or normal rabbit gamma globulin. One hour after the last injection 




















hippocampus and frontal cortex were taken for analysis of histamine¬ 
like substances, under the assumption that elevated histamine-like 
activity would be indicative of an antigen-antibody reaction. The 
results of this study revealed a statistically significant increase 
(P = 0.01) of histamine-like substances in the caudate only when 
anti-caudate antibody was injected and a corresponding specific 
increase in those substances in the hippocampus when its antibody 
was injected. 
If these experiments can be confirmed a tool is available to 
induce specific inhibition of electrical activity in specified 
brain regions and perhaps to selectively inhibit a myriad of additional 
"specific" brain functions not yet completely identified. 
In an investigation of neuronal electrogenesis, Mihailovic et al. 
(120) applied anti-lobster nerve antibody to the giant axon of lobsters 
and observed the action potential and resting potential at hourly 
intervals. The most significant changes attributed to the action 
of the antibody were the progressive decrease in the resting potential 
and the deterioration of the action potential. It was also demon¬ 
strated that nerves bathed in an immune gamma globulin lost twice 
as much potassium as nerves bathed in normal gamma globulin. Hence, 
a suggestion was made that antibody may increase the nerve membrane's 
permeability to potassium. Similar electrical changes were found by 






















In this section antibody was prepared to whole unperfused cat 
caudate, cat hippocampus, and pig caudate according to the technique 
of Mihailovic and Jankovic (118); antibody was also prepared to 
saline-perfused cat caudate and hippocampus. All antisera were 
tested by Ouchterlony gel immunodiffusion. Precipitin activity, 
specific to the caudate or hippocampus was searched for in all 
Ouchterlony plates. 
Chapter IV. Preparation of Antisera 
Antigens 
All cats used in this study were obtained from Yale University 
Department of Animal Care. Early in the work cat brains were collected 
from animals which had been used in other experiments, terminally 
or soon after death. Many brains came from cats used by Yale medical 
students in their Physiology course. 
When perfused brains were specifically desired, animals were 
anesthetized with pentobarbital 25 mg/kg and a thoracotomy performed. 
Normal saline at a pressure of 2-4 feet was administered through a 
cannula inserted into the left ventricle; the descending aorta was 
clamped and the right heart was opened. The absence of visible blood 
in the fine capillaries of the choroid plexus and the lack of a 
precipitin reaction when the antigen suspension was tested with 
Hyland rabbit anti-cat serum, were used as indices of an adequate 
perfusion. 
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The cat brains were stored in ice immediately after removal 
from the skull. The caudate and hippocampus were freed by blunt 
dissection. White matter was obtained from the corpus callosum 
and internal capsule by careful sharp dissection and samples of 
cortical grey were removed in thin slices with a razor. 
Unperfused pig brains were obtained from the Sperry Barnes 
Packing Company, formerly of New Haven, and from Connecticut 
Packers, Bloomfield, Connecticut. Pigs were stunned by electroshock 
or by a bullet shot into the head, and then bled from the neck. 
The skull was divided by a cleaver and the brain always removed 
in two pieces. All brains were put into ice within one hour of he 
animal's death. Caudate and hippocampus were bluntly dissected; 
the white matter was removed by sharp dissection. 
All antigens were stored in small vials at -20°C. for periods 
of up to one year. 
Immunization Methods 
The antigen for immunization was homogenized itfith known amounts 
of saline, usually at 20 per cent w/v, in a glass Potter-Elvehjem 
tissue grinder with a teflon pestle. An equal amount of Freund 
Complete Adjuvant, (Difco, Detroit, Michigan), was added to the 
homogenate which was mixed to emulsion. New, white, New Zealand 
rabbits received a total of 1.5 ml of immunizing emulsion, 0.15- 
0.20 ml in each of four toe pads, the remainder of the emulsion 
was injected subcutaneously into multiple sites on the rabbit's 
back. Booster injections contained the antigen in saline or in a 
. 
. 















few cases in Freund adjuvant. In recent experiments rabbits were 
first anesthetized with a combination of pentobarbital and ethyl 
ether before receiving the painful toepad injections. 
The sheep were initially immunized with antigen in Freund 
complete adjuvant injected into four sites on the back subcutaneously 
and boosted with an intravenous injection of the antigen in saline. 
Control bleedings were obtained from all animals prior to immunization. 
A detailed immunization for the experimental animals is presented. 
Bleedings of Animals 
Rabbits were bled at two to three week intervals from the ear. 
Following vasodilatation induced by topical xylene a razor cut 
through a major vein provided 30 to 60 ml of whole blood. The sheep 
were bled 50-150 ml every two weeks with a #13 x 3M needle in the 
jugular vein. All animals received Imferon (Lakeside Laboratories), 











4/6/64 Injected with 250 mg. unperfused cat caudate homo¬ 
genized in Freund complete adjuvant. Total volume 
1.5 ml; 0.15 ml in one toe pad of each foot, 
remainder intradermally and subcutaneously into 
multiple sites on back. 
4/20/64 Test bleed, neg. 
5/6/64 Boosted with 200 mg cat caudate in saline (s.c.). 
5/28/64 Boosted with 250 mg cat caudate in saline (s.c.). 
6/3/64 Test bleed, active sera. 
6/17/64 Boosted with 250 mg cat caudate in saline (s.c.). 
7/3/64 Bleed (from 7/3-11/11 boosting data not available) 
7/9/64 Bleed 
7/28/64 Bleed 
* 8/4/64 Bleed 
*11/11/64 Bleed 











2/17/65 2.5 g unperfused cat caudate in FCA (ID). 
3/1/65 Bleed and boost, 0.75 g cat caudate in saline 
(s. c.). 
3/18/65 Bleed, Boost, 0.75 g cat caudate in saline (s.c.) 
3/25/65 Bleed and boost, 1.0 g cat caudate in saline (IV) 
4/2/65 Animal ataxic, impairment of righting reflex. 
4/8/65 Bleed and boost, 1.5 g cat caudate in FCA,(weak 
but alert^ 
4/16/65 Sacrificed by exsanguination. 
Serum from final bleeding was used in experiments. 
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11/14/64 Inject 0.7 g pig caudate FCA (s.c.), 0.7 g pig 
caudate in saline (IV). 
12/3/64 Bleed and boost, 0.5 g pig caudate in saline (IV) (s.c.) 
12/16/64 Bleed and boost, 0.5 g pig caudate in saline (IV) (s.c.) 
1/13/65 Bleed and boost, 1.0 g pig caudate in saline (IV) (s.c.) 
2/9/65 Bleed and boost, 3.0 g pig caudate in FCA (IM). 
2/17/65 Bleed and boost, 2.5 g pig caudate, 2.0 ml mouse serum* 
in FCA (s.c.). 
3/1/65 Bleed and boost, 1,0 g pig caudate, 1.0 ml mouse serum* 
in FCA (s.c.). 
3/2/65 Animal weak, often falling to ground has tonic, clonic 
movements of all four extremities. 
3/5/65 Animal sacrificed by exsanguination. 
Serum from final bleeding was used in experiments. 
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4/27/65 Injected with 350 mg of perfused cat hippocampus 
homogenate in Freund complete adjuvant (FCA). Total 
volume 1.5 ml. 0.15 ml injected into one toe pad on 
each food, remainder injected into multiple sites on 
back intradermally. 
5/14/65 Boosted with 350 mg hippocampus in saline (s.c.). 
7/1/65 Boosted with 350 mg hippocampus in FCA (s.c.). 
7/12/65 Test bleed, negative. 
7/14/65 Boosted with 350 mg hippocampus in FCA (s.c.). 


















4/29/65 Injected 500 mg perfused cat caudate homogenate in 
equal amounts of Freund complete adjuvant. Total 
volume 1.5 ml. 0.15 ml injected into one toe pad 
on each foot. Remainder into multiple sites on back 
intradermally. 
5/14/65 Boosted with 500 mg cat caudate in saline, subcutaneously 
7/1/65 Test bleed, negative. 
7/2/65 Boosted with 500 mg cat caudate in FCA (s.c.). 
7/12/65 Test bleed, negative. 
7/14/65 Boost with 250 mg cat caudate in FCA (s.c.). 
* 7/26/65 Bleed, positive. 
8/13/65 Bleed 




1/5/66 Boosted with 100 mg cat caudate IV, and 100 mg (s.c.) 
with FCA. 
1/10/66 Bleed 












Ouchterlony Double Immunodiffusion 
"Immunoplates," patterns A and C were obtained from Hyland 
Laboratories (Los Angeles, California). These micro agar-diffusion 
plates contained one central well and six equidistant peripheral wells 
with a center-to-center distance between central and peripheral wells 
of 4 mm, 5 mm and 7 mm. The 4 and 6 mm distances were usually optimal 
for maximum resolution; many lines did not appear at 7 mm separation. 
Antigens and antibody were put into the wells with micropipettes 
drawn from melting point capillary tubes. Plates were stored overnight 
in a moist chamber and examined the next morning for lines of antigen- 
antibody precipitation. 
When lines were faint, concentration of the antigen by dialysis 
against Carbowax flakes or 30per cent solution (Union Carbide) often 
served to intensity the reaction. A concentration of two to five times 
was regularly achieved but because of the small volume and high viscosity 
of the concentrate, accurate measurements were not possible. 
In early experiments with Rabbit 33, Ouchterlony plates were 
visualized in the oblique light of a fluorescent desk lamp and 
photography was not possible. Following the construction of a darkfield 
illumination all results were photographed. 
Visualization of Ouchterlony Lines--Darkfield Illumination 
A major problem in the use of the Ouchterlony double diffusion 
technique in agar has been the lack of an appropriate optical system 
which would allow accurate recording of even the faintest precipitin 









this problem by various methods of direct illumination of the agar 
plate, none of which have been very successful. It is only with 
oblique or "darkfield" illumination that the almost invisible bands 
of the precipitin reaction are visualized against the colorless agar. 
The illuminator employed in these experiments was a refinement of 
a prototype conceived by Dr. Nobuya Ohtoma working in the laboratory 
of Dr. Henry Treffers. 
The illuminator is housed within a square box 14 x 14 x 8 inches. 
A round aperture 4 1/2 inches in diameter is present in the center 
of its hinged lid. Aperture inserts were designed to accommodate 
Immunoplates and microscope slides. The light source is a commercially 
available 8 inch circular fluorescent tube which supports an overlapping 
45 degree truncated aluminum cone. In the central axis of the box, an 
adjustable baffle has been placed whose function is to block all direct 
illumination from appearing at the aperture. With these conditions, 
the only light reaching the aperture is oblique^ 
Photography 
Photographic recording of results was obtained with a Bessler 4x5 
enlarger equipped with a 75 mm Polaroid lens in combination with a close 
up lens, (Kodak plus 3, 5, 10). This enlarger was adapted to 
accommodate the Polaroid 4x5 film holder; type P/N 55 film was used 
with its advantage of a negative which could be stored for later 
reproduction of results. 
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Chapter V. Testing of Sera 
I. Experiments with Unperfused Brain Antigens 
When unperfused brain regions were used as antigen according to 
the techniques of Mihailovic and Jankovic, the resulting antisera 
reacted strongly with the immunizing antigen in many different 
lines in the Ouc'hterlony plate. The strongest reaction was always 
seen with serum from the antigen donor, and the continuity of these 
reaction lines identified serum as the major contaminant in all 
preparations of regional brain antigens. In addition to serum 
lines, one to three other continuous lines were found only with 
brain tissue antigens. These lines were found to be continuous 
between species, (i.e, pig and cat, rabbit and cat) identifying 
the antibrain antibody as organ specific. Occasionally, in well- 
resolved Ouchterlony plates an additional line precipitated with 
caudate, but not with hippocampus, callosum, or any other antigen 
tested, however, this observation was not routinely reproducible. 
Variations in antigen concentration were also observed to alter 
the number of lines of visible precipitation. 
A. Rabbit 33--Immunized with unperfused cat caudate. 
Rabbit 33 had antibodies to cat caudate, hippocampus, superior 
and inferior colliculus, spinal cord, kidney and serum. It also reacted 



















Figure I demonstrates some reactions of R 33. There are definitely 
two lines shared by the 3 cat antigens and questionably, by pig 
caudate. An additional line with cat caudate and cat callosum are 
faintly visible. There is no visible reaction with pig callosum. 






B. Sheep 209-210—Immunized with unperfused cat caudate. 
Figure II 
Figure II demonstrates the significant antibody response of the sheep 
to the small amounts of cat serum contained in the immunizing antigens. 
It also shows the presence of cat serum proteins in the cat caudate 
and cat callosum antigens. A system of two antibrain antibodies 
also appears to be present in both cat and pig antigens. There is an 
additional sharp line (innermost) opposite the cat brain antigens 
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The problem of interpreting the Ouchterlony plates when 
antigens are serum contaminated is illustrated in Figures III and 
IV. In Figure III the four lines with antiserum and hippocampus A 
each cross the cat serum line. Therefore, each of these lines must 
be interpreted as representing an antigen-antibody reaction different 
from any of the many cat serum protein-anti cat serum protein reactions. 
Figure III 
However, when the reagents were rearranged as in Figure IV, six 
lines with serum appeared, each looking suspiciously similar to 







respectively. Reliable information could not be obtained from such 
inconsistent Ouchterlony plates. 
Figure IV 
The observation that the number of lines obtainable with a regional 
brain antigen decrease with storage is demonstrated in Figure III. 
The A and B suspensions of cat caudate and hippocampus were both 
made at 20 per cent w/v. Suspension B was one month old, A was 





C. Sheep 5-6--Immunized with unperfused pig caudate. 
The use of pig caudate for antigen was undertaken because of 
the abundance of fresh pig brains in New Haven. Since all pig 
brains used were grossly bloody it was not unexpected that the 
major precipitating activity of the sera was against pig serum 
(Fig. V). However, strong antibrain antibody was evident after 
the antisera was absorbed with pig serum (Fig. VI). Although it 
does not show well, pig caudate and pig callosum were found to 
share three antigens in common, each different from pig serum. The 
sheep serum was also observed to react with other brain antigens, cat 















II. The Problem of Serum Contamination 
The massive antibody response of rabbit and sheep to small 
amounts of serum protein in the brain antigens quickly became the 
limiting factor in the interpretation of Ouchterlony data. Since 
all brain antigens used for immunization contained highly antigenic 
serum proteins, there was no doubt that along with anti-brain antibodies, 
anti-serum antibodies were being produced. Moreover, since these 
contaminated brain antigens were also being used for testing, except 
for absorptions.(see Figure VI)^ it became impossible to positively 
identify a line as belonging to the brain or serum system. The 
solution to this problem was to eliminate as much serum protein as 
possible from the brain antigens. Accordingly in the following 
experiments cat brains were saline perfused, and tested for the 
presence of serum, before their use as immunizing or test antigens. 
Ill. Experiments with Saline-Perfused Brain Antigens 
In these experiments rabbits were immunized with essentially 
serum-free, saline-perfused, cat caudate and cat hippocampus. 
The change to perfused antigens resulted in the absence of precipitating 
anti-cat serum activity in the early rabbit bleedings, and only 
one or two faint lines after many booster injections. At the same 
time, one, and sometimes two, concentric lines of identity 
precipitated with all the cat brain regions. No difference was 
seen between the sera resulting from caudate or hippocamus injections. 
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A. Rabbit 25—Immunized with perfused cat hippocampus. 
B. Rabbit25--Immunized with perfused cat caudate. 
Figure VII—Rabbit 25 Figure VIII--Rabbit 25 
There was no difference between the sera of the two rabbits. Both 
reacted in two concentric lines with all cat brain antigens. 
Significantly, the usual lines with cat serum were absent. Cat 





Chapter VI. Conclusion 
Mihailovic and Jankovic reported on the production of antibody 
to the cat caudate and cat hippocampus specific in its ability 
to extinguish the EEC activity and to increase the histamine-like 
content in the homologous brain region. Although "two to three 
lines” in immunodiffusion were reported when cat caudate was 
tested with its antiserum, no other brain regions were tested, so 
it was not known if precipitating specificity was actually obtained. 
In this thesis antibody was first prepared without perfusion 
of brain tissue. Sera manufactured in this manner contained high 
titer antibodies to the traces of serum proteins which were unavoidably 
present in the injections of brain homogenates. Moreover, when these 
brain homogenates were used for Ouchterlony testing, at least 
two separate antigen-antibody systems were found to be operating: 
serum protein- anti serum protein, and brain-anti brain. It was only 
with exhaustive absorption of the anti serum-protein activity, 
(which was done with Sheep 5-6), that other non-serum-protein reactions 
could be definitely uncovered. 
Because of this complication, antisera was prepared and tested 
using saline-perfused brain antigens. This new sera no longer reacted 
with serum proteins, but neither did it demonstrate any caudate or 
hippocampus specificity. The antibody that was produced reacted 
equally well with all parts of the cat brain: caudate nucleus, hippocampus, 
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It has not been possible to demonstrate specific precipitating 
antibody to unique water-soluble, gel-diffusible substances of the 
caudate nucleus. Ouchterlony tests were not able to distinguish 
the caudate nucleus from any other brain region with antibody. 
Whether other species of antibody will harbor the claimed EEG and 
histamine-increase specificity remains to be tested, although to 
date, workers have failed to demonstrate caudate uniqueness with 
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